Guidance for Treating Pregnant Women with Opioid Use Disorder Released

Feb 08, 2018 - 12:48 PM

The Substance Abuse and Mental Health Services Administration today issued new clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants. The guidance consists of 16 factsheets containing clinical recommendations and resources to help health care professionals make evidence-informed decisions based on individual patient needs and local circumstances. “SAMHSA is filling an urgent need for reliable, useful and accurate information for health care professionals working to treat opioid-dependent mothers and their children,” said Elinore McCance-Katz, SAMHSA assistant secretary for mental health and substance use. “Ultimately, the steps explained in this guidance will help the mother and her infant safely receive treatment for opioid use disorder and neonatal abstinence syndrome.” In other news, the Senate Health, Education, Labor and Pensions Committee today held a hearing on the opioid crisis and its impact on children and families. Witnesses included Stephen Patrick, M.D., a pediatrician and neonatologist at Monroe Carell Jr. Children’s Hospital at Vanderbilt in Nashville and an assistant professor of pediatrics and health policy at Vanderbilt University School of Medicine.
 

Related News Articles

Headline
FDA issues guidance to expand non-opioid treatments for chronic pain
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
Study finds less than 40% of Medicare beneficiaries with OUD receive standard care
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
FDA announces labeling changes to opioid pain medications 
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…
Headline
Overdose deaths dropped an estimated 27% in 2024
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported…
Headline
FDA approves first-in-class non-opioid painkiller 
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
AHA podcast: Englewood Health's Strategies to Combat Rising Opioid Use in Post-Pandemic America
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…